SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0000950123-08-003700
Filing Date
2008-04-01
Accepted
2008-04-01 17:06:17
Documents
8
Effectiveness Date
2008-04-01

Document Format Files

Seq Description Document Type Size
1 FORM S-3 y52661sv3asr.htm S-3ASR 611611
2 EX-5.1: OPINION OF SAUL EWING LLP y52661exv5w1.htm EX-5.1 5550
3 EX-8.1: OPINION OF HOGAN & HARTSON L.L.P. y52661exv8w1.htm EX-8.1 8073
4 EX-12.1: COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES y52661exv12w1.htm EX-12.1 12106
5 EX-23.1: CONSENT OF KPMG LLP y52661exv23w1.htm EX-23.1 2521
6 EX-25.1: A STATEMENT OF ELIGIBILITY ON FORM T-1 y52661exv25w1.htm EX-25.1 33083
8 GRAPHIC y52661y5266102.gif GRAPHIC 1480
9 GRAPHIC y52661y5266103.gif GRAPHIC 2203
  Complete submission text file 0000950123-08-003700.txt   679808
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-150027 | Film No.: 08730203
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1